Expertise in
11
conditions

Boris A. Hadaschik

Essen, NW, DE 
Expertise in
11
conditions
Essen, NW, DE 

Overview

Boris Hadaschik practices practicing medicine in Essen, Germany.

Mr. Hadaschik is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Urachal Cancer, Familial Prostate Cancer, Prostatectomy, and Cystectomy.

He is actively involved in clinical research, co-authoring 453 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Essen, NW, Germany
Other Locations
Duisburg, NW, Germany
Berlin, BE 14163, Germany
Heidelberg, BW, Germany
Mannheim, BW, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Evaluation of the TULSA-PRO MRI-Guided Transurethral Ultrasound Prostate Ablation Device in Patients With Localized Prostate Cancer: a Prospective, Single-Arm, Pivotal Clinical Study
Evaluation of the TULSA-PRO MRI-Guided Transurethral Ultrasound Prostate Ablation Device in Patients With Localized Prostate Cancer: a Prospective, Single-Arm, Pivotal Clinical Study
Enrollment Status: Active_not_recruiting
Publish Date: August 17, 2025
Intervention Type: Device
Study Phase: Not Applicable
Neoadjuvant and Adjuvant Durvalumab in Combination With Neoadjuvant Chemotherapy in Patients With Operable Urothelial Cancer. A Multicenter, Single-arm Phase II Trial
Neoadjuvant and Adjuvant Durvalumab in Combination With Neoadjuvant Chemotherapy in Patients With Operable Urothelial Cancer. A Multicenter, Single-arm Phase II Trial
Enrollment Status: Completed
Publish Date: May 04, 2025
Intervention Type: Drug
Study Drug: Durvalumab
Study Phase: Phase 2
View 1 Less Clinical Trial

453 Total Publications

Comparative effectiveness of apalutamide-, abiraterone-, and enzalutamide-based doublets in mHSPC.
Comparative effectiveness of apalutamide-, abiraterone-, and enzalutamide-based doublets in mHSPC.
Journal: BJU international
Published: September 01, 2026

Frequently Asked Questions about Boris A. Hadaschik

Is Boris A. Hadaschik a top-rated expert for Prostate Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Boris A. Hadaschik is classified as an Elite expert for Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Boris A. Hadaschik participate in research or clinical trials?

Yes. Boris A. Hadaschik has published 453 articles and abstracts on conditions like Prostate Cancer. You can view a list of Boris A. Hadaschik's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Hadaschik's expertise for a condition
ConditionClose
View All 25 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile